IQ EQ Fund Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
16,279
+1,471
+10% +$160K 0.16% 133
2026
Q1
$1.37M Sell
14,808
-3,642
-20% -$366K 0.1% 175
2025
Q4
$1.88M Buy
18,450
+3,380
+22% +$302K 0.13% 145
2025
Q3
$942K Sell
15,070
-30,254
-67% -$1.65M 0.06% 212
2025
Q2
$2.36M Buy
45,324
+36,320
+403% +$1.62M 0.21% 129
2025
Q1
$384K Buy
+9,004
New +$388K 0.05% 251

Other funds holding GH

IQ EQ Fund Management's GH Position: Q2 2026 in Review

IQ EQ Fund Management increased its Guardant Health (GH) stake by 9.9% in Q2 2026, buying an estimated $160K and bringing the position to 16,279 shares worth $2.44M. The position accounts for 0.16% of the portfolio, ranked #133.

IQ EQ Fund Management first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • IQ EQ Fund Management held 16,279 shares of Guardant Health worth $2.44M as of Q2 2026.
  • IQ EQ Fund Management bought 1,471 Guardant Health shares in Q2 2026, an estimated $160K.
  • Guardant Health made up 0.16% of IQ EQ Fund Management's portfolio in Q2 2026, its #133 holding.
  • IQ EQ Fund Management first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.